The University of Chicago Header Logo
Last Name


Shin Tsunekawa to Diabetes Mellitus, Type 2

This is a "connection" page, showing publications Shin Tsunekawa has written about Diabetes Mellitus, Type 2.

Connection Strength
  1. Kawai M, Himeno T, Shibata Y, Hirai N, Asada-Yamada Y, Asano-Hayami E, Ejima Y, Kasagi R, Nagao E, Sugiura-Roth Y, Nakai-Shimoda H, Nakayama T, Yamada Y, Ishikawa T, Morishita Y, Kondo M, Tsunekawa S, Kato Y, Nakamura J, Kamiya H. Neuroretinal dysfunction revealed by a flicker electroretinogram correlated with peripheral nerve dysfunction and parameters of atherosclerosis in patients with diabetes. J Diabetes Investig. 2021 Jul; 12(7):1236-1243.
    View in: PubMed
    Score: 0.112
  2. Miura Y, Yamamoto N, Tsunekawa S, Taguchi S, Eguchi Y, Ozaki N, Oiso Y. Replacement of valsartan and candesartan by telmisartan in hypertensive patients with type 2 diabetes: metabolic and antiatherogenic consequences. Diabetes Care. 2005 Mar; 28(3):757-8.
    View in: PubMed
    Score: 0.038
  3. Yamada Y, Himeno T, Tsuboi K, Shibata Y, Kawai M, Asada-Yamada Y, Hayashi Y, Asano-Hayami E, Hayami T, Ishida Y, Ejima Y, Motegi M, Asano S, Kato M, Nagao E, Nakai-Shimoda H, Ishikawa T, Morishita Y, Kondo M, Tsunekawa S, Kato Y, Nakayama T, Kamei M, Nakamura J, Kamiya H. Alterations of retinal thickness measured by optical coherence tomography correlate with neurophysiological measures in diabetic polyneuropathy. J Diabetes Investig. 2021 Aug; 12(8):1430-1441.
    View in: PubMed
    Score: 0.028
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.